(Q42764021)

6 November 2017

0 references

Zanamivir for influenza: a public health perspective. Its use will require careful management by GPs. (English)

1 reference

6 November 2017

0 references

1 reference

Jonathan Nguyen Van-Tam

series ordinal

1

1 reference

PMC publication ID

1116528

6 November 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

6 November 2017

1 reference

6 November 2017

319

1 reference

6 November 2017

7211

1 reference

6 November 2017

655-656

1 reference

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

6 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1116528

Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993-4 epidemic: results of serum testing and questionnaire

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1116528

Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1116528

Rational design of potent sialidase-based inhibitors of influenza virus replication

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1116528

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1116528

Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1116528

Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10480805

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The impact of three influenza epidemics on primary care in England and Wales

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10480805

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.319.7211.655

1 reference

6 November 2017

1 reference

PMC publication ID

1116528

6 November 2017

PubMed publication ID

10480805

1 reference

PMC publication ID

1116528